Contemporary OB/GYN week in review: STI epidemic, HPV vaccine, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OB/GYN week in review: STI epidemic, HPV vaccine, and more
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, January 1 - Friday, January 5, 2023), and click each link to read and watch anything you may have missed.
1.) Behavioral shifts driving STI epidemic: A deep dive
A recent study explores how changing sexual behaviors influence rising sexually transmitted infection rates, underscoring the need for comprehensive prevention strategies.
Click here for the full article.
2.) Long-term HPV vaccine efficacy: 10-year study reveals protection in youth
A decade-long study confirms significant protection against human papillomavirus remains in patients vaccinated up to age 20, reinforcing the World Health Organization's single-dose vaccination recommendation for adolescents.
Click here for the full article.
3.) The clinical takeaways of the RSV immunizations
The panel discusses the importance of discussing the immunizations with patients now, as well as the value of them in future seasons.
Click here for the full article.
4.) FDA warns of false positive HSV-2 test risks
The FDA emphasized the need for cautious herpes simplex virus type 2 serological testing, highlighting factors that increase the likelihood of false positives and urging adherence to CDC guidelines.
Click here for the full article.
5.) Digital health interventions reduce postpartum anxiety and depression
A recent meta-analysis reveals that digital health interventions significantly alleviate symptoms of postpartum anxiety and depression, underscoring their potential as accessible treatments for new mothers.
FDA grants 510(k) clearance to cobas liat STI multiplex assay panels
Published: January 22nd 2025 | Updated: January 22nd 2025The new panels, leveraging rapid polymerase chain reaction technology, allow point of care sexually transmitted infection diagnosis in 20 minutes, enhancing targeted treatment and reducing follow-up losses.
Read More
Timely surveillance reported in under half of HPV-positive patients
January 20th 2025A recent study highlights gaps in cervical cancer screening compliance, with fewer than 50% of human papillomavirus-positive, negative for intraepithelial lesion or malignancy patients receiving recommended follow-up testing within the guideline time frame.
Read More
